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ABSTRACT 
  
 Detrusor underactivity (DU) increases susceptibility to urinary retention and accordingly 
further complicates the management of urinary incontinence.  Bladder muscle stretch, a lack of 
estrogen, and aging are 3 notable DU risk factors.  The aim of this research is to better 
characterize the changes in cellular composition of the bladder that result from these 3 risk 
factors to gain a better understanding of DU pathogenesis and pathobiology.  This research 
focuses on the effects of a lack of estrogen while also providing an outline for determining the 
effects of bladder muscle stretch and aging on the cellular composition of the bladder.  
 5 transgenic mice underwent bilateral ovariectomy and 2 sham control animals were 
established.  The mice exhibited endogenous fluorescence for collagen 3.6 and alpha smooth 
muscle actin (α-SMA) and antibodies were used to detect vimentin and calponin.  1 week post 
surgery, decreased expression of α-SMA and calponin revealed a loss of smooth muscle and a 
more pronounced decrease in calponin expression compared to α-SMA expression suggested that 
following ovariectomy the smooth muscle transitions to a less mature smooth muscle cell (SMC) 
phenotype.   
 Further studies are needed to better characterize both the endogenous fluorescence in 
transgenic mice and the changes in cellular composition of the bladder in DU pathogenesis and 
pathobiology.      
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INTRODUCTION 
 
 The detrusor muscle is made of smooth muscle and constitutes a layer of the urinary 
bladder wall.  Detrusor underactivity (DU) is defined as, “a contraction of reduced strength 
and/or duration, resulting in prolonged bladder emptying and/or a failure to achieve complete 
bladder emptying within a normal time span” [1].  DU increases susceptibility to urinary 
retention and accordingly further complicates the management of urinary incontinence.  Like 
urinary incontinence, DU is especially common in geriatric populations.  Moreover, although 
other risk factors exist, bladder muscle stretch, a lack of estrogen, and aging are 3 notable risk 
factors and their effects interact through a common pathway. 
 Useful animal models exist for all 3 of these notable DU risk factors.  Partial bladder 
outlet obstruction (pBOO) surgery has been used as an animal model for DU in mice with the 
characteristic symptoms of sarcopenia and fibrosis being reproducibly achieved 3 weeks 
following surgery [1].  Similarly, bilateral ovariectomy provides a useful animal model for a lack 
of estrogen.  When using animal models to investigate aging, it is important to include multiple 
age groups that are neither too young nor too old [2].  Furthermore, care must be taken to ensure 
and provide evidence that aged animals are pathogen free.          
 The aim of this research is to characterize the changes in the cellular composition of the 
mouse bladder that result from DU by examining the changes in cellular composition due to 
muscle stretch, lack of estrogen, and aging.  Although smooth muscle predominates, the bladder 
also comprises other tissue types, including epithelial, nervous, macrophages, and connective.  
DU is characterized by changes in these tissues involving bladder muscle loss (sarcopenia), 
fibrosis, and axonal degeneration [3]. 
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 Many cell types retain some level of plasticity, allowing them to modify their phenotypes 
in response to environmental changes and genetic programs.  SMCs exhibit significant plasticity, 
allowing them to both quickly and reversibly change phenotype in response to environmental 
cues [4].  Different SMC phenotypes correspond to different SMC functions throughout 
development, tissue repair, and disease [4].  Additionally, a unique set of marker proteins are 
characteristic of each phenotypic state.  The expression of marker proteins in SMC 
differentiation and maturation can be considered along a continuum in which marker proteins of 
less differentiated SMC are first expressed in earlier developmental stages while marker proteins 
of more mature SMCs are expressed in later stages of SMC development.  Although this 
continuum of SMC development was traditionally interpreted as signifying that all mature SMCs 
developed from the least differentiated SMCs, a recent study suggests that SMC precursors give 
rise to naïve SMCs, which have a synthetic phenotype, but then give rise to a variety of SMC 
phenotypes along the continuum [5].  As in the earlier perspective of SMC development, this 
new model also recognizes the high degree of plasticity exhibited by SMCs.  Furthermore, 
investigations of the SMC phenotypic diversity recognized contractile and synthetic SMCs as 
being at opposite ends of the SMC phenotypic spectrum [5].  Contractile SMCs are elongated, 
spindle-shaped, and contain many contractile filaments [5].  Synthetic SMCs are less elongated, 
contain many organelles needed for protein synthesis, and have higher growth rates as well as 
greater migratory activity.  Contractile and synthetic SMCs, as well as the various intermediate 
SMC phenotypes, can be distinguished with marker proteins.   
 In the presented research, changes in the smooth muscle of the mouse bladder due to 
bladder muscle stretch and a lack of estrogen are monitored by observing changes in the relative 
numbers of cells expressing α-SMA and calponin following pBOO or bilateral ovariectomy.  
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αSMA is a commonly used marker protein for less differentiated SMCs whereas calponin is 
expressed in more mature SMCs [4].  Following one of the prescribed treatments, an increase in 
the number of SMCs expressing αSMA and a decrease in those expressing calponin would 
indicate that the smooth muscle tissue became less differentiated, towards a synthetic phenotype, 
which characterizes sarcopenia and would be expected following bladder muscle stretch, a lack 
of estrogen, or aging.     
 Similar to SMCs, fibroblasts also exhibit significant plasticity and are monitored in this 
research by observing the changes in the relative numbers of cells expressing 2 marker proteins, 
collagen 3.6 and vimentin.  Increases in both marker proteins are characteristic of fibrosis and 
therefore expected following bladder muscle stretch, a lack of estrogen, or aging.  Figure 1 
provides a summary of the expected changes in all 4 examined marker proteins following each 
treatment.  
 
 
 
 
 
 
 
  
 
 
Figure 1.  Proposed Changes in Bladder Composition with Injury. 
Studies suggest that following partial bladder outlet obstruction (pBOO), there is 
initially a period of hypertrophy preceding the muscle atrophy and fibrosis that is 
observed in longer-term studies  
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 This research is important as it could increase our limited understanding of DU 
pathophysiology and pathogenesis, which will allow for the development of more effective, 
rather than simply palliative, treatments for urinary incontinence.  Currently, urinary 
incontinence in the frail elderly is treated mostly with behavioral therapies while research on 
treatment options remains limited  [6].  On a broader scale and by considering the general 
simplicity of the bladder, this research may contribute to the understanding of other geriatric 
problems by serving as a model for a better understanding of both pathogenesis and treatment in 
more complex tissues.      
 
  
MATERIALS AND METHODS 
 
 Animal care.  Double transgenic mice with fluorescent markers for αSMA (mcherry, red) 
and 3.6 collagen (cyan, blue) were obtained from the lab of Dr. Ivo Kalajzic at the University of 
Connecticut Health Center.  These mice were then bred and maintained in accordance with the 
National Institute of Health guidelines.  A local animal care committee approved all procedures 
and the mice were allowed ad libitum access to food and water.   
 Animal surgeries.  All surgeries were performed on 5 wk old female mice.  5 mice 
underwent bilateral ovariectomies.  7 mice underwent partial bladder outlet obstruction (pBOO) 
as previously described [1], of which 2 died after surgery.  Following both surgeries, mice were 
sacrificed 1 week post surgery.  Similarly, sham controls were established for both surgeries, 2 
for ovariectomies and 4 for pBOO.     
 Tissue collection and dissociation. Mice were euthanized with isofluorane.  After rinsing 
the abdomens with ethanol, the bladders were immediately extracted, blotted dry, and placed in 
cold PBS solution.  In sterile conditions, the bladders were finely minced with a scalpel and razor 
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blade and then introduced to filtered dissociation buffer (collagenase P in PBS with a final 
concentration of 1 mg/mL passed through a 0.2 µm filter).  Following trituration through the fire-
polished tip of a Pasteur pipette, the samples were placed in a 37°C shaker for 45 min.  An equal 
volume of trypsin was then added to each sample and the reaction was allowed to continue for 5 
min in a 37°C water bath.  During this time, the samples were shaken twice.  The reactions were 
stopped by adding 10% FBS.  Next, samples were passed through a 70 µm filter and centrifuged 
at 1500 rpm for 5 min.  The obtained pellet was re-suspended in 8 mL of wash buffer (10% FBS 
in PBS) and centrifuged as before.  The pellet was re-suspended in 1 mL of medium 
(DMEM/F12 with 10% FBS+P/S, 50x dilution).  Cell count was then ascertained using a drop of 
this suspension and Trypan blue under 10x magnification.   
 Sample preparation for FACS analysis.  Samples were prepared for FACS analysis in one 
of 2 ways, depending on whether or not antibodies were incorporated into the sample analysis.  
The first method, for fluorescent samples for which antibodies were not incorporated, involved 
first washing the cells 2 times with FACS buffer (into a 1.5 mL tube and adding 1.2 mL FACS 
buffer).  The samples were then centrifuged at 1300 rpm for 5 min at 4°C.  500 µL of FACS 
buffer was added to the obtained pellets and after mixing by vortexing, the samples were ready 
for FACS analysis.   
 The second FACS preparation method, for samples analyzed with antibodies, involved 
first following the above procedure for samples not incorporating analysis with antibodies.  
These samples were then fixed by adding 150 µL fixing buffer, vortexing, and waiting 30 min.  
The antibodies were then introduced as described below.  Next, the samples were washed with 
500 µL FACS buffer, centrifuged as before, and the obtained pellet mixed with 500 µL FACS 
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buffer via vortexing.  Unlike the unfixed samples, these samples could be stored at 4°C and did 
not need to immediately undergo FACS analysis.             
 Immunohistochemistry.  Monoclonal antibodies against vimentin and calponin were 
obtained from Abcam (ab8978) and Sigma (C2687) respectively.  Monoclonal antibody labeling 
kits were obtained from Invitrogen and used to conjugate vimentin and calponin to the 
fluorophores Alexa Fluor 647 and Pacific Blue respectively.  The conjugated antibodies were 
introduced to the fixed cells by first permeabilizing the cells with permeabilization buffer 
(eBioscience) and then incubating the permeabilized cells on ice with the antibodies for 25 min.  
 Tissue characterization.  FACS analysis was used to analyze all samples.  The efficacy of 
the transgenic markers cherry and cyan, for αSMA and collagen 3.6 respectively, was tested by 
comparing the cherry and cyan signals for wild type, cyan only, cherry only, and double 
transgenic mice.  This analysis was performed using the FACSAria machine. 
 The efficacy of staining with fluorophore conjugated antibodies against vimentin and 
calponin was assayed by comparing the Alexa Fluor and Pacific Blue signals for cell samples 
treated with the antibodies to unstained cells.  This analysis was performed using the LSR II 
machine. 
 The changes in bladder cellular composition following ovariectomy and pBOO were 
investigated by comparing the signals from the 4 markers for αSMA , collagen 3.6, vimentin, and 
calponin, between the mice that had undergone ovariectomy or pBOO and their corresponding 
sham controls.  All mice were double transgenic and the FACSAria machine was used.     
     
 
 
 
 
 
RESULTS 
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 The fluorescence of both cyan and cherry in the untreated double transgenic mouse was 
comparable to the corresponding fluorescence in each of the single transgenic controls, showing 
that neither signal is disrupted in the double transgenic control (Figure 2).  For example, 16.1 + 
0.51 = 16.61% of cells in the cyan only control expressed cyan whereas 6.42 + 9.18 = 15.6% of 
cells in the double transgenic mouse expressed cyan.  Additionally, 9.18% of cells in the double 
transgenic bladder expressed both cyan and cherry and are therefore considered myofibroblasts. 
 
 
 
 
 
 
 
 Following cell fixation, nearly a 50% reduction in the endogenous fluorescence of the 
transgenic fluorophores was obtained.  This is evident in Figure 3, which shows cherry 
expression in the double transgenic mouse before fixing, 9.18 + 32 = 41.18%, and after fixing, 
21%. 
 
 
 
 
 
Figure 2.  Efficacy of Cherry and Cyan Markers 
This data was obtained from the FACSAria machine and shows that cherry and cyan are 
suitable markers for α-SM actin and collagenase 3.6 respectively in the double transgenic 
mouse model.  
Figure 3.  Changes in 
Cherry Fluorescence 
when Cells are Fixed   
The cherry signal of 2 
double transgenic mice 
is compared and shows 
that fixing the cells 
reduces the endogenous 
cherry fluorescence by 
approximately 50%, from 
41.18% to 21%.  SSC-A 
refers to side scatter.   
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 Cells from double transgenic mice were stained with antibodies against vimentin and 
calponin.  The anti-calponin antibody is conjugated to the Pacific Blue fluorophore.  In Figure 4, 
the no staining sample shows that there is a small amount of overlap between the signals for 
collagen 3.6 (cyan) and calponin, which is why the Pacific Blue label is retained throughout the 
figure.  However, the overlap is only 1.75% and accordingly is not considered significant.  
Overall, it is evident that 1 week post ovariectomy, the percentage of cells stained for calponin 
decreases, 5.13 + 50.2 = 55.23% compared to 7.25 + 60.3 = 67.55%.  A small decrease is also 
observed in vimentin, 10.6 + 50.2 = 60.8% compared to 4.36 + 60.3 = 64.66%.   
 
 
 
 
 
 
 
 
 
 Due to the overlap between the cyan and Pacific Blue, the fluorophores for collagen 3.6 
and calponin respectively, the changes in cyan expression 1 week post ovariectomy could be not 
ascertained.  Given the relatively minor contribution of endogenous cyan to the Pacific Blue 
signal (Figure 4: No Staining), the overlap is not considered to significantly impact the calponin 
expression as determined by the Pacific Blue signal.  The changes in αSMA, calponin, and 
vimentin expression following ovariectomy can therefore be ascertained and are illustrated in 
Figure 4.  Double Staining and Cellular Composition Changes in the Bladder with Ovariectomy 
1 week post ovariectomy, there is a significant decrease in calponin expression and slight decrease in 
vimentin expression.   
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Figure 5.  1 week post ovariectomy, significant decreases in expression are observed in αSMA  
(14.7% compared to 21%) and calponin (52.9 + 29.9 = 82.8% compared to 51.7 + 40.2 = 91.9%) 
while a slight increase is observed in vimentin expression (1.78 + 52.9 = 54.68% compared to 
0.36 + 51.7 = 52.06%) 
 Similar changes in protein expression, that being decreases in αSMA and calponin 
expression accompanied by an increase in vimentin expression, are expected to also occur with 
pBOO. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Changes in Cellular 
Composition of the Bladder 
with Ovariectomy 
Overall, 1 week following 
ovariectomy, decreases in cherry 
fluorescence (corresponding to 
αSMA expression) and calponin 
expression are observed.  The 
above Pacific Blue expression is 
attributed to calponin because 
the overlap with cyan is 
insignificant.  Vimentin 
expression slightly increases 1 
week post ovariectomy.     
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DISCUSSION 
 The presented results demonstrate that 1 week following ovariectomy, there is a 
significantly decreased expression of αSMA and calponin as well as a slight increase in vimentin 
expression.  This corresponds to muscle degeneration and fibrosis, which are both characteristic 
of DU.  These findings confirm that bilateral ovariectomy provides a useful model of DU, even 1 
week following surgery. 
 In the double transgenic, untreated animal, 9.18% of the cells fluoresced both cyan and 
cherry.  These cells may represent myofibroblasts although the percentage of myofibroblasts in 
the healthy bladder was not expected to be this high.  Using a pBOO model, Bouro et al. 
proposed that following bladder injury, serosal thickening is achieved in a 2 step process in 
which mesenchymal cells adopt a myofibroblast phenotype first and then transition into a fetal 
SMC phenotype [7].  Therefore, in the injured bladder, myofibroblasts play a crucial role in 
tissue remodeling and may be more abundant following bladder injury.  
 The purpose of this research is to better characterize the pathogenesis and pathobiology 
of DU and it was found that following ovariectomy, there is a general trend towards less 
differentiated SMC.  This dedifferentiation is evident in that calponin, which is a more mature 
SMC marker than α-SM actin, exhibited a more pronounced decrease in expression than αSMA  
1 week after ovariectomy (Calponin expression decreased 91.9 – 82.8 = 9.1 % whereas αSMA 
expression decreased 21 – 14.7 = 6.3%).  Similarly, vimentin, which is an early fibroblast marker 
did not exhibit a significant change in expression. 
 It is also important to note that, especially with the endogenous fluorescence, the 
percentage of cells exhibiting fluorescence of a particular fluorophore may not represent the 
actual percentage of cells expressing the corresponding marker within a sample.  This is 
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especially evident in Figure 3 which shows that fixing cells from double transgenic samples 
reduces their fluorescence by approximately 50%.  Moreover, although αSMA is an earlier SMC 
marker than calponin and would therefore be expressed in all SMCs that express calponin, only 
21% of cells from the Sham control expressed αSMA while 91.9% expressed calponin (Figure 
5).  Further studies are needed to better characterize the endogenous fluorescence in transgenic 
mice, as explained in “Future Directions.” Nevertheless, the change in fluorescence of each 
fluorophore provides valuable information on how the expression of each marker changes.   
 
 
CURRENT RESEARCH 
 
 
Additional Considerations  
 The presented research investigated how bladder muscle stretch and a lack of estrogen 
affect the bladder cellular composition.  The current research investigates the effects of aging on 
bladder cellular composition.  Although this is a continuation of the previous study, there are 
several important points and differences to consider.  First, although some studies suggest aging 
contributes to DU [3], a study by Brierly et al. found no correlation between DU and age [8].  In 
addition to these mixed findings, the possibility of comorbidities further complicates aging 
studies and care must be taken when selecting which age groups to study.  Similarities are 
evident between developmental and aging processes such that many of the observed 
physiological changes characteristic of development are thought to occur in the opposite 
direction during aging.  In other words, aging may resemble dedifferentiation.  Accordingly, 3 
different age groups are examined during this study to include young, old, and intermediate aged 
mice. 
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 The differences between the current research and the presented research are highlighted 
in the following section.  In addition to a new tissue collection and dissociation protocol, the cell 
types examined and accordingly also the marker proteins employed present notable differences.  
For example, in addition to SMCs and fibroblasts, the changes in the relative numbers of 
urothelial cells and macrophages are also investigated.  Keratin 17 is used as an urothelial protein 
marker and F4/80 as a macrophage marker because it is the only well studied macrophage 
marker that does not overlap in specificity with fibroblasts [9].  Moreover, fibroblast-specific 
protein 1 (FSP1) is used to detect fibroblasts because it is specific for fibroblasts [10] whereas 
vimentin is also expressed in myofibroblasts and fetal type SMCs [11].  Finally, αSMA is 
examined through the use of immunohistochemistry rather than transgenic mice.  A summary of 
these markers is presented in Figure 6 and differences between this research and the presented 
research are further detailed below.  
 
Modifications in Materials and Methods  
 Animal care.  Aged wild type female mice are acquired from the National Institute on 
Aging (NIA).  In total, 30 mice are ordered, such that on the date of the experiment there will be 
approximately 10 each of 2 month, 12 month, and 24 month old mice.  
 Tissue collection and dissociation. Mice are euthanized with CO2.  After saturating the 
abdomen with 70% ethanol, the bladders are exposed, taking care to avoid puncturing the liver 
while also excising fat and connective tissue.  The bladder is held in place with forceps while a 
30G1/2 needle is used to inject 250 µL dissociation solution (collagenase 2 in PBS, 2 mg/mL 
final concentration) into the bladder lumen.  Throughout the next 5 min, additional injections of 
dissociation solution are made in different regions of the bladder between the urothelium and 
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smooth muscle layer.  This should require approximately 3 mL dissociation solution.  Exactly 5 
min after the first injection, the bladder is extracted, placed in a 60x15 mm culture dish, and 
incubated at 37°C for 10 min.  It is then minced with scissors in the hood and again incubated at 
37°C for 5 min.  The tissue sample is then gently and slowly titurated with a 1 mL pipette 10 
times and again incubated at 37°C for 5 min.  The tituration is repeated and the resulting cloudy 
solution is filtered through a 0.2 µm cell strainer into a 50 mL falcon tube.  Cold PBS is used to 
wash the culture dish until the 50 mL falcon tube contains a total volume of 10 mL.  This 
suspension is poured into a 15 mL falcon tube and 5 mL of cold PBS is used to wash the 50 mL 
falcon tube.  The 15 mL falcon tube is centrifuged at 1400 RPM for 5 min.  13 mL of the 
supernatant are then extracted and the primary cell pellet is resuspended using a 1 mL pipette.  
15 mL of cold PBS are added to the resuspended pellet and the suspension is centrifuged as 
before.  14.5 mL of the supernatant are extracted and the cell pellet is again resuspended using a 
pipette.  Cell count is then ascertained using 20 µL of this suspension and Trypan blue under 10x 
magnification.  A minimum cell density of 105 cells/mL will achieve best results. 
 Immunohistochemistry.  Antibodies against α-SMA (Abcam – ab8211), FSP-1 (Abcam – 
2795), keratin 17 (Cell Signaling – 4543), and F4/80 (ebioscience – 47-4801) are used and 
conjugated to FITC (preconjugated), Alexa Fluor 680 (Invitrogen – A20172), Pacific Blue 
(Invitrogen – P30013), and APC-Cy7 (preconjugated) respectively (Figure 6).  As illustrated in 
Figure 7, these fluorophores do not significantly overlap.  Prior to staining the dissociated 
bladder with these antibodies, titrations of each antibody in a cell line of each investigated type 
of tissue will be conducted to determine the ideal antibody concentrations.     
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Figure 6. Summary of Markers and Fluorophores Used to Analyze the Effects of 
Aging on Bladder Cellular Composition. 4 tissue types are examined.   
 
 
 
 
 
 
 
 
 
  
Sample preparation for FACS analysis & tissue characterization.  Sample preparation for 
FACS analysis and tissue characterization will be performed as done earlier, after first 
establishing compensation controls for each of the antibodies used.   
 
FUTURE DIRECTIONS  
 To strengthen these findings, the presented experiments should be repeated using larger 
sample sizes.  Moreover, bladders were examined 1 week post surgery and the long term impact 
of bilateral ovariectomy and pBOO should also be investigated.   
 The changes in cellular composition accompanying bladder injury can be better 
characterized by using additional marker proteins to target different cell types as well as different 
levels of differentiation within a single cell type.  However, in addition to financial 
considerations, there are several limitations to the number of antibodies that can be used 
simultaneously.  First, only 3 intracellular proteins can be stained simultaneously without 
obtaining interference.  Furthermore, there are limits to the number of non-overlapping 
fluorophores available for conjugation.  Similarly, not all antibodies of interest are commercially 
available.  For example, although smoothelin is an ideal marker for a mature contractile SMC 
Tissue Antibody Fluorophore 
Smooth 
Muscle 
αSMA FITC 
Fibroblast FSP-1 Alexa Fluor 
680 
Urothelium Keratin 17 Pacific Blue 
Macrophage F4/80 APC-Cy7 
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phenotype [5] and would therefore be a very valuable marker for tissue characterization, it is not 
commercially available.  
 Studies should also be performed to better characterize the endogenous fluorescence 
exhibited in transgenic mice.  Endogenous fluorescence from transgenic mice may be indicative 
of whether or not a particular protein is being synthesized, that is if its promoter is activated, 
rather than whether or not the protein is present in the cell as is ascertained by 
immunohistochemistry.  The efficacy of the endogenous fluorescence as a marker can be 
determined by treating tissue samples from transgenic mice with conjugated antibodies for the 
marker of interest and then comparing the fluorescence from both.  If the endogenous 
fluorescence proves to be an adequate marker then more antibodies can be used.  Plans to 
complete an experiment of this nature are already forming, which is why mcherry, the 
fluorophore for αSMA in the transgenic mouse model, is included in the fluorescence spectrum 
(Figure 7) with the other fluorophores being used in the current aging study.  If the endogenous 
fluorescence is confirmed as an adequate marker for αSMA, then the fluorophore FITC could be 
conjugated to another marker, such as calponin, rather than αSMA.    
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 Finally, the tissue characterization techniques established throughout these experiments 
can be used to analyze changes in the bladder cellular composition associated with a variety of 
treatments such as current plans to demonstrate how MIF tautomerase inhibitor (ISO-1) partially 
relieves bladder muscle loss and fibrosis following bilateral ovariectomy.  Macrophage migration 
inhibitory factor (MIF) is a cytokine that is released by the urothelium into the bladder lumen 
following injury and is an essential component of the inflammation processes [12]. ISO-1 blocks 
MIF by blocking its tautomerase activity.  The aim of the presented research is to better 
characterize DU pathophysiology and pathogenesis and further studies of ISO-1 and MIF could 
therefore be very valuable because MIF is essential to the pathways responsible for the 
Figure 7. Fluorophores Used to Analyze the Effects of Aging on Bladder Cellular Composition. 
This figure was generated using the fluorescence spectrum viewer program available at 
www.bdbiosciences.com and illustrates that the fluorophores being used in the aging study do not 
significantly overlap.  Pacific Blue is conjugated to anti-keratin 17, FITC to anti-αSMA, Alexa Fluor 680 to 
an antibody against FSP-1, and APC-Cy7 to an antibody against F4/80.  Although wild type mice are 
used, cherry is endogenous fluorescence of αSMA and included above for future studies with transgenic 
mice.   
21 
 
characteristic attributes of DU that result from bladder muscle stretch, lack of estrogen, and 
aging. 
 
CONCLUSION 
 
 1 week post ovariectomy, smooth muscle degeneration and fibrosis of the bladder are 
evident.  The smooth muscle degeneration resembles a dedifferentiation in which SMC 
phenotypes transition towards less mature SMC phenotypes.  Further studies are needed to better 
characterize both the endogenous fluorescence in transgenic mice and the changes in cellular 
composition of the bladder in DU pathogenesis and pathobiology.      
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